Every one of those 1 sits in a single category, regulation. Private equity firms is most often covered alongside Buprenorphine, which appears in 1 of these 1 story. Each story carries 4 original sources on average, compared with 2.3 for the broader beat in this window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Private equity firms
Every one of those 1 sits in a single category, regulation. Private equity firms is most often covered alongside Buprenorphine, which appears in 1 of these 1 story. Each story carries 4 original sources on average, compared with 2.3 for the broader beat in this window. Their average consequence score of 6 runs below the beat's 6.2 for that window. Private equity firms appears in 1 tracked Finance story from September 12, 2026.
Stories tracked
1
Sources per story
4
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 42 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Private equity firms. Shared-story counts are live from our verified record — not editorial picks.
For investors, the methadone clinic system is a textbook regulatory-moat business: daily-visit, publicly reimbursed recurring revenue owned by private-equity-backed and publicly traded chains. The investigation highlights why the moat that made it attractive is now a political risk as lawmakers scrutinize private-equity ownership in addiction care.
Private equity firms is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.